Global Bronchodilators Market Growth Is Driven By Rising Prevalence Of Respiratory Diseases

The global bronchodilators market has been witnessing steady growth over the past few years owing to high prevalence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Bronchodilators are drugs that help open up constricted airways and make breathing easier. Some common types of bronchodilators include beta2-agonists, muscarinic antagonists/anticholinergics, and xanthines. These drugs work by relaxing the muscles in the airways and increasing airflow to the lungs. The increasing geriatric population susceptible to respiratory conditions and growing pollution levels leading to higher cases of asthma attacks are fueling the sales of bronchodilators globally.
The Global Bronchodilators Market is estimated to be valued at US$ 22.85 BN in 2024 and is expected to exhibit a CAGR of 3.7% over the forecast period 2024 to 2031.